| IL-17 regulates adipogenesis, glucose homeostasis, and obesity LA Zúñiga, WJ Shen, B Joyce-Shaikh, EA Pyatnova, AG Richards, ... The Journal of Immunology 185 (11), 6947-6959, 2010 | 456 | 2010 |
| Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis BA Zabel, S Nakae, L Zúñiga, JY Kim, T Ohyama, C Alt, J Pan, H Suto, ... The Journal of experimental medicine 205 (10), 2207-2220, 2008 | 380 | 2008 |
| Th17 cell development: from the cradle to the grave LA Zúñiga, R Jain, C Haines, DJ Cua Immunological reviews 252 (1), 78-88, 2013 | 264 | 2013 |
| Peroxisome proliferator–activated receptor (PPAR) α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity SE Dunn, SS Ousman, RA Sobel, L Zuniga, SE Baranzini, S Youssef, ... The Journal of experimental medicine 204 (2), 321-330, 2007 | 216 | 2007 |
| Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance MC Ernst, ID Haidl, LA Zúñiga, HJ Dranse, JL Rourke, BA Zabel, ... Endocrinology 153 (2), 672-682, 2012 | 205 | 2012 |
| Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-β and TLR ligands BA Zabel, T Ohyama, L Zuniga, JY Kim, B Johnston, SJ Allen, DG Guido, ... Experimental hematology 34 (8), 1106-1114, 2006 | 198 | 2006 |
| Chemoattractants, extracellular proteases, and the integrated host defense response BA Zabel, L Zuniga, T Ohyama, SJ Allen, J Cichy, TM Handel, EC Butcher Experimental hematology 34 (8), 1021-1032, 2006 | 195 | 2006 |
| Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease KL Graham, BA Zabel, S Loghavi, LA Zuniga, PP Ho, RA Sobel, ... The Journal of Immunology 183 (10), 6717-6723, 2009 | 109 | 2009 |
| A bone‐protective role for IL‐17 receptor signaling in ovariectomy‐induced bone loss J Goswami, N Hernández‐Santos, LA Zuniga, SL Gaffen European journal of immunology 39 (10), 2831-2839, 2009 | 102 | 2009 |
| A highly focused antigen receptor repertoire characterizes γδ T cells that are poised to make IL-17 rapidly in naive animals YL Wei, A Han, J Glanville, F Fang, LA Zuniga, JS Lee, DJ Cua, Y Chien Frontiers in immunology 6, 118, 2015 | 57 | 2015 |
| GITR Agonism Enhances Cellular Metabolism to Support CD8+ T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model SS Sabharwal, DB Rosen, J Grein, D Tedesco, B Joyce-Shaikh, R Ueda, ... Cancer Immunology Research 6 (10), 1199-1211, 2018 | 51 | 2018 |
| Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice HL Penny, TR Prestwood, N Bhattacharya, F Sun, JA Kenkel, ... Cancer immunology research 4 (11), 917-926, 2016 | 46 | 2016 |
| The novel adipokine chemerin significantly increases cholesterol uptake in human macrophages TC McCarthy, LA Zuniga, BA Zabel, EC Butcher, CJ Sinal The FASEB Journal 22, 948.8-948.8, 2008 | 27 | 2008 |
| TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic … DB Rosen, AM Kvarnhammar, B Laufer, T Knappe, JJ Karlsson, E Hong, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 22 | 2022 |
| Compromised aortic vasoreactivity in male estrogen receptor-α-deficient mice during acute lipopolysaccharide-induced inflammation AM Corbacho, JP Eiserich, LA Zuniga, G Valacchi, AC Villablanca Endocrinology 148 (3), 1403-1411, 2007 | 21 | 2007 |
| Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine … LA Zúñiga, T Leßmann, K Uppal, N Bisek, E Hong, CE Rasmussen, ... Cancer Cell International 22 (1), 286, 2022 | 11 | 2022 |
| CMKLR regulation of adipogenesis and adipocyte metabolic function C Sinal, K Goralski, T McCarthy, L Zuniga, B Zabel, E Butcher US Patent App. 11/800,116, 2007 | 10 | 2007 |
| Methods for screening for modulators of ccrl2 BA Zabel, EC Butcher, SJ Galli, S Nakae, L Zuniga US Patent App. 12/541,056, 2010 | 8 | 2010 |
| 16 Tumor growth inhibition mediated by a single dose of intratumoral TransCon™ TLR7/8 agonist was associated with activated circulating T and B cells and sustained low levels … A Mirza, L Zuniga, K Uppal, K Bang, E Hong, S Sabharwal, Y Lee, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A18-A18, 2021 | 5 | 2021 |
| Anti-ILT4 antibodies and antigen-binding fragments B Joyce-Shaikh, LA Zuniga, M Blanusa, AC Schuster, K Schultze US Patent 11,053,315, 2021 | 5 | 2021 |
